
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $727M | $1B | $1.2B | $1.4B | $1.6B | |
Revenue Growth (YoY) | -69.58% | 42.67% | 19.18% | 16.78% | 12.16% | |
Cost of Revenues | $426M | $604.9M | $759.7M | $899M | $1B | |
Gross Profit | $301M | $432.3M | $476.4M | $544.5M | $618.8M | |
Gross Profit Margin | 41.4% | 41.68% | 38.54% | 37.72% | 38.22% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $177.2M | $223.9M | $244.7M | $264.5M | $305.1M | |
Other Inc / (Exp) | $84.9M | $151.8M | -$27.4M | -$5.2M | -$11M | |
Operating Expenses | $170.8M | $215.8M | $235.6M | $264.5M | $252.3M | |
Operating Income | $130.2M | $216.5M | $240.8M | $280M | $366.5M | |
Net Interest Expenses | $92.1M | $108.3M | $69.3M | $38.3M | $71.9M | |
EBT. Incl. Unusual Items | $123M | $260M | $144.1M | $236.5M | $283.6M | |
Earnings of Discontinued Ops. | $247M | $220.2M | $314.9M | $1.2B | -$3M | |
Income Tax Expense | $53.4M | $59.9M | $34.7M | $37.1M | $69.1M | |
Net Income to Company | $69.6M | $200.1M | $109.4M | $199.4M | $214.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $316.6M | $420.3M | $424.3M | $1.4B | $211.5M | |
Basic EPS (Cont. Ops) | $1.70 | $2.30 | $2.37 | $8.79 | $1.63 | |
Diluted EPS (Cont. Ops) | $1.69 | $2.29 | $2.35 | $8.73 | $1.61 | |
Weighted Average Basic Share | $187M | $182.5M | $179.1M | $161.6M | $130.1M | |
Weighted Average Diluted Share | $187.5M | $183.5M | $180.4M | $162.6M | $131M | |
EBITDA | $255.7M | $278.6M | $312.2M | $368.8M | $472.4M | |
EBIT | $215.1M | $216.5M | $240.8M | $280M | $366.5M | |
Revenue (Reported) | $727M | $1B | $1.2B | $1.4B | $1.6B | |
Operating Income (Reported) | $130.2M | $216.5M | $240.8M | $280M | $366.5M | |
Operating Income (Adjusted) | $215.1M | $216.5M | $240.8M | $280M | $366.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $701M | $296M | $344.5M | $388.7M | $403.2M | |
Revenue Growth (YoY) | 21.28% | -57.78% | 16.39% | 12.83% | 3.73% | |
Cost of Revenues | $454M | $188.7M | $217.8M | $242.5M | $252.7M | |
Gross Profit | $247M | $107.3M | $126.7M | $146.2M | $150.5M | |
Gross Profit Margin | 35.24% | 36.25% | 36.78% | 37.61% | 37.33% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $129M | $63.2M | $62.6M | $72.3M | $86.3M | |
Other Inc / (Exp) | $27M | $3M | -$7.4M | -$3.6M | $100K | |
Operating Expenses | $129M | $61.1M | $61.7M | $69.8M | $82.8M | |
Operating Income | $118M | $46.2M | $65M | $76.4M | $67.7M | |
Net Interest Expenses | $55M | $16.9M | $13.3M | $15.5M | $16.9M | |
EBT. Incl. Unusual Items | $90M | $32.3M | $44.3M | $57.3M | $50.9M | |
Earnings of Discontinued Ops. | -- | $58.4M | $1.2B | -$1.9M | -$700K | |
Income Tax Expense | $22M | $9.3M | $11.4M | $14M | $12.6M | |
Net Income to Company | $68M | -$29.8M | $1.2B | $41.4M | $37.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $68M | $81.4M | $1.2B | $41.4M | $37.6M | |
Basic EPS (Cont. Ops) | $0.37 | $0.45 | $7.15 | $0.32 | $0.29 | |
Diluted EPS (Cont. Ops) | $0.37 | $0.45 | $7.11 | $0.32 | $0.29 | |
Weighted Average Basic Share | $182M | $179.8M | $171.7M | $129.8M | $127.6M | |
Weighted Average Diluted Share | $183M | $181M | $172.7M | $130.7M | $128.2M | |
EBITDA | $168M | $66.8M | $78.2M | $98.4M | $96.2M | |
EBIT | $145M | $49.2M | $57.6M | $72.8M | $67.8M | |
Revenue (Reported) | $701M | $296M | $344.5M | $388.7M | $403.2M | |
Operating Income (Reported) | $118M | $46.2M | $65M | $76.4M | $67.7M | |
Operating Income (Adjusted) | $145M | $49.2M | $57.6M | $72.8M | $67.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $896M | $266.5M | $1.3B | $1.5B | $1.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $538M | $89.7M | $827.7M | $948.3M | $1B | |
Gross Profit | $358M | $176.8M | $502.4M | $580M | $641.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $210.2M | $101.3M | $249.9M | $282.7M | $327.4M | |
Other Inc / (Exp) | $103.9M | $108.3M | -$73.4M | $24.2M | -$3.3M | |
Operating Expenses | $203.8M | $88.3M | $242.9M | $280.4M | $202.1M | |
Operating Income | $154.2M | $88.5M | $259.5M | $299.6M | $439.1M | |
Net Interest Expenses | $113.1M | $67.2M | $67.4M | $35.4M | $77.2M | |
EBT. Incl. Unusual Items | $145M | $129.6M | $118.7M | $288.4M | $358.6M | |
Earnings of Discontinued Ops. | -- | $111.2M | $1.5B | -$32.9M | -$2.1M | |
Income Tax Expense | $56.4M | $27.3M | $6.6M | $71.7M | $89.1M | |
Net Income to Company | $88.6M | $102.3M | $1.4B | -$1B | $270.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $335.6M | $433.7M | $1.6B | $183.8M | $267.4M | |
Basic EPS (Cont. Ops) | $1.82 | $2.39 | $9.06 | $1.27 | $2.06 | |
Diluted EPS (Cont. Ops) | $1.82 | $2.38 | $9.00 | $1.26 | $2.06 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $319.1M | $103.5M | $299M | $392.4M | $551.8M | |
EBIT | $258.1M | $45M | $223M | $292.5M | $439.7M | |
Revenue (Reported) | $896M | $266.5M | $1.3B | $1.5B | $1.7B | |
Operating Income (Reported) | $154.2M | $88.5M | $259.5M | $299.6M | $439.1M | |
Operating Income (Adjusted) | $258.1M | $45M | $223M | $292.5M | $439.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.4B | $583.3M | $677.3M | $762.1M | $817.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $879M | $363.8M | $431.8M | $481.1M | $514.1M | |
Gross Profit | $475M | $219.5M | $245.5M | $281M | $303.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $246M | $123.4M | $128.6M | $146.8M | $169.1M | |
Other Inc / (Exp) | $53M | $9.5M | -$36.5M | -$7.1M | $600K | |
Operating Expenses | $246M | $118.5M | $125.8M | $141.7M | $91.5M | |
Operating Income | $229M | $101M | $119.7M | $139.3M | $211.9M | |
Net Interest Expenses | $75M | $33.9M | $32M | $29.1M | $34.4M | |
EBT. Incl. Unusual Items | $207M | $76.6M | $51.2M | $103.1M | $178.1M | |
Earnings of Discontinued Ops. | -- | $111.2M | $1.2B | -$3.9M | -$3M | |
Income Tax Expense | $52M | $19.4M | -$8.7M | $25.9M | $45.9M | |
Net Income to Company | $155M | $57.2M | $1.3B | $73.3M | $129.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $155M | $168.4M | $1.3B | $73.3M | $129.2M | |
Basic EPS (Cont. Ops) | $0.84 | $0.93 | $7.62 | $0.56 | $1.00 | |
Diluted EPS (Cont. Ops) | $0.84 | $0.93 | $7.57 | $0.56 | $1.00 | |
Weighted Average Basic Share | $367M | $360.3M | $346.9M | $261.6M | $256.3M | |
Weighted Average Diluted Share | $369M | $363M | $349M | $263.4M | $257.7M | |
EBITDA | $326M | $145M | $122.3M | $182.4M | $268.9M | |
EBIT | $282M | $110.5M | $83.2M | $132.2M | $212.5M | |
Revenue (Reported) | $1.4B | $583.3M | $677.3M | $762.1M | $817.5M | |
Operating Income (Reported) | $229M | $101M | $119.7M | $139.3M | $211.9M | |
Operating Income (Adjusted) | $282M | $110.5M | $83.2M | $132.2M | $212.5M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $760M | $122.6M | $23.4M | $409.1M | $68.3M | |
Short Term Investments | -- | -- | -- | $347.5M | -- | |
Accounts Receivable, Net | $409M | $50M | $56.2M | $64M | $73.2M | |
Inventory | $199M | $27.4M | $29.4M | $33.3M | $39.7M | |
Prepaid Expenses | $45M | -- | -- | -- | -- | |
Other Current Assets | -- | $27.3M | $38M | $65.5M | $61M | |
Total Current Assets | $1.4B | $1B | $1.6B | $936.7M | $255.4M | |
Property Plant And Equipment | $874M | $785.9M | $916.7M | $1.1B | $1.3B | |
Long-Term Investments | $44M | -- | -- | -- | -- | |
Goodwill | $445M | $512.8M | $548.2M | $578M | $615.3M | |
Other Intangibles | $84M | $129.5M | $114.9M | $102.6M | $90.3M | |
Other Long-Term Assets | $115M | $725.7M | $215.9M | $187.8M | $220.4M | |
Total Assets | $3.1B | $3.2B | $3.4B | $2.9B | $2.4B | |
Accounts Payable | $189M | $38.6M | $45M | $118.7M | $117.4M | |
Accrued Expenses | $255M | $139.2M | $172.6M | $215.9M | $212.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $375.9M | $539.3M | $3.9M | -- | |
Total Current Liabilities | $444M | $568.7M | $919.4M | $362.3M | $353.9M | |
Long-Term Debt | $2B | $1.6B | $1.5B | $1.6B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3.1B | $3.1B | $3.1B | $2.7B | $2.3B | |
Common Stock | $2M | $1.8M | $1.8M | $1.3M | $1.3M | |
Other Common Equity Adj | $8M | $7.5M | -$21.3M | $13.2M | $9.9M | |
Common Equity | -$76M | $134.5M | $306.6M | $203.2M | $185.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$76M | $134.5M | $306.6M | $203.2M | $185.6M | |
Total Liabilities and Equity | $3.1B | $3.2B | $3.4B | $2.9B | $2.4B | |
Cash and Short Terms | $760M | $122.6M | $23.4M | $756.6M | $68.3M | |
Total Debt | $2B | $1.7B | $1.7B | $1.6B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $247M | $118M | $2.3B | $494.5M | $61.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $426M | $551M | $57M | $94.3M | $79.3M | |
Inventory | $218M | $276M | $33.5M | $37.5M | $41.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $55M | $59M | $29M | $59.8M | $40.5M | |
Total Current Assets | $968M | $1B | $2.5B | $701.4M | $230M | |
Property Plant And Equipment | $1B | $1.2B | $981.2M | $1.2B | $1.3B | |
Long-Term Investments | $45M | $53M | -- | -- | -- | |
Goodwill | $617M | -- | -- | -- | -- | |
Other Intangibles | $115M | -- | -- | -- | -- | |
Other Long-Term Assets | $117M | $222M | $168M | $203.3M | $223.1M | |
Total Assets | $2.9B | $3.2B | $4.3B | $2.8B | $2.5B | |
Accounts Payable | $180M | $238M | $85.8M | $118.8M | $102.5M | |
Accrued Expenses | $267M | $300M | $512M | $221.1M | $189.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $448M | $585M | $621.6M | $963.7M | $315.6M | |
Long-Term Debt | $1.7B | $1.6B | $1.6B | $951.3M | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3B | $3B | $2.9B | $2.7B | $2.2B | |
Common Stock | $2M | $2M | $1.7M | $1.3M | $1.3M | |
Other Common Equity Adj | $16M | $15M | $17.9M | $13.1M | $2.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$56M | $200M | $1.4B | $60.1M | $248.7M | |
Total Liabilities and Equity | $2.9B | $3.2B | $4.3B | $2.8B | $2.5B | |
Cash and Short Terms | $247M | $118M | $2.3B | $494.5M | $61.9M | |
Total Debt | $1.7B | $1.7B | $1.6B | $1.6B | $1.1B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $69.6M | $200.1M | $109.4M | $199.4M | $214.5M | |
Depreciation & Amoritzation | $40.6M | $62.1M | $71.4M | $88.8M | $105.9M | |
Stock-Based Compensation | $12.1M | $13.7M | $14.4M | $12.2M | $12M | |
Change in Accounts Receivable | $1.7M | -$17.4M | -$17.5M | $26.4M | -$900K | |
Change in Inventories | -$2.3M | -$5.3M | -$5.4M | -$3.3M | -$7.7M | |
Cash From Operations | $371.7M | $403.9M | $284.2M | -$40.8M | $265.1M | |
Capital Expenditures | $94M | $103.1M | $132M | $180.5M | $224.4M | |
Cash Acquisitions | -$40.1M | -$281.7M | -$50.7M | -$36.3M | $18.8M | |
Cash From Investing | -$222.6M | -$399.9M | -$207.6M | $2B | $136.8M | |
Dividends Paid (Ex Special Dividend) | -$84.3M | -$90.9M | -$89.2M | -$21.8M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.4B | $527.9M | $23M | $921M | $200M | |
Long-Term Debt Repaid | -$926.4M | -$800M | -$38.1M | -$920.9M | -$698.8M | |
Repurchase of Common Stock | -$59.8M | -$126.9M | -$142.6M | -$1.5B | -$226.8M | |
Other Financing Activities | -$18.8M | -$36.2M | -$16M | -$19M | -$20.7M | |
Cash From Financing | $450.3M | -$535.5M | -$218.9M | -$1.7B | -$746.3M | |
Beginning Cash (CF) | $159.4M | $760.5M | $231.4M | $83.9M | $413.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $599.4M | -$531.5M | -$142.3M | $329.3M | -$344.4M | |
Ending Cash (CF) | $760.5M | $231.4M | $83.9M | $413.1M | $68.7M | |
Levered Free Cash Flow | $277.7M | $300.8M | $152.2M | -$221.3M | $40.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $68M | -$29.8M | $1.2B | $41.4M | $37.6M | |
Depreciation & Amoritzation | $23M | $17.6M | $20.6M | $25.6M | $28.4M | |
Stock-Based Compensation | $3M | $4M | $2.5M | $2.5M | $2.6M | |
Change in Accounts Receivable | -$21M | -$2.7M | -$8.6M | -$25.5M | -$4.1M | |
Change in Inventories | -$9M | -$3.1M | -$2.7M | -$7.7M | -$3.4M | |
Cash From Operations | $111M | $64M | $118.8M | $68.3M | $47.2M | |
Capital Expenditures | $39M | $25.7M | $39.5M | $44.9M | $51.8M | |
Cash Acquisitions | -$5M | -$9.8M | -$9.3M | -$16.7M | -$5.2M | |
Cash From Investing | -$31M | -$38.4M | $2.6B | $58.3M | -$53.7M | |
Dividends Paid (Ex Special Dividend) | -$23M | -$22.5M | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $535M | -- | $670.9M | -- | $50M | |
Long-Term Debt Repaid | -$800M | -- | -$789.6M | -$5.9M | -$6M | |
Repurchase of Common Stock | -$42M | -$34.8M | -$170M | -$40.5M | -$31.1M | |
Other Financing Activities | -$28M | -$2.3M | -$3.2M | -$6.5M | -$4.6M | |
Cash From Financing | -$358M | -$59.7M | -$460M | -$52.9M | $8.3M | |
Beginning Cash (CF) | $528M | $153.7M | $93M | $420.7M | $60.4M | |
Foreign Exchange Rate Adjustment | -$2M | $600K | -$1M | $100K | $100K | |
Additions / Reductions | -$278M | -$34.1M | $2.2B | $73.7M | $1.8M | |
Ending Cash (CF) | $248M | $120.2M | $2.3B | $494.5M | $62.3M | |
Levered Free Cash Flow | $72M | $38.3M | $79.3M | $23.4M | -$4.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $88.6M | $102.3M | $1.4B | -$1B | $270.4M | |
Depreciation & Amoritzation | $53.6M | $52.6M | $76M | $99.9M | $112.1M | |
Stock-Based Compensation | $15.1M | $14.9M | $12.6M | $11.7M | $11.7M | |
Change in Accounts Receivable | -$56.3M | -$10.8M | -$5.3M | -$1.5M | $19.7M | |
Change in Inventories | $4.7M | $7.7M | -$9.1M | -$4.3M | -$7M | |
Cash From Operations | $407.7M | $309.7M | $298.5M | -$62.7M | $265.3M | |
Capital Expenditures | $111M | $86.8M | $153.7M | $188.3M | $242.6M | |
Cash Acquisitions | -$252.1M | -$82.1M | -$46.2M | -$42.4M | $155.2M | |
Cash From Investing | -$427.6M | -$208.1M | $2.4B | -$252.6M | -$83.5M | |
Dividends Paid (Ex Special Dividend) | -$88.3M | -$89.9M | -$66M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $848.5M | -$18.1M | $943.9M | $100K | $275M | |
Long-Term Debt Repaid | -$1.3B | -- | -$947.1M | -$23.7M | -$778.9M | |
Repurchase of Common Stock | -$99.8M | -$93.2M | -$333.7M | -$1.5B | -$91.4M | |
Other Financing Activities | -$31.8M | -$16.4M | -$16.9M | -$20.5M | -$17.8M | |
Cash From Financing | -$517.7M | -$228M | -$482.9M | -$1.5B | -$613.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$537.6M | -$126.4M | $2.2B | -$1.8B | -$431.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $296.7M | $222.9M | $144.8M | -$251M | $22.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $155M | $57.2M | $1.3B | $73.3M | $129.2M | |
Depreciation & Amoritzation | $44M | $34.5M | $39.1M | $50.2M | $56.4M | |
Stock-Based Compensation | $6M | $7.2M | $5.4M | $4.9M | $4.6M | |
Change in Accounts Receivable | -$14M | -$7.4M | $4.8M | -$23.1M | -$2.5M | |
Change in Inventories | -$13M | -- | -$3.7M | -$4.7M | -$4M | |
Cash From Operations | $190M | $95.8M | $110.1M | $88.2M | $88.4M | |
Capital Expenditures | $74M | $57.7M | $79.4M | $87.2M | $105.4M | |
Cash Acquisitions | -$223M | -$23.4M | -$18.9M | -$25M | $111.4M | |
Cash From Investing | -$276M | -$84.2M | $2.5B | $230.6M | $10.3M | |
Dividends Paid (Ex Special Dividend) | -$46M | -$45M | -$21.8M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $546M | -- | $920.9M | -- | $75M | |
Long-Term Debt Repaid | -$800M | -- | -$909M | -$11.8M | -$91.9M | |
Repurchase of Common Stock | -$100M | -$66.3M | -$257.4M | -$212.2M | -$76.8M | |
Other Financing Activities | -$31M | -$11.2M | -$12.1M | -$13.6M | -$10.7M | |
Cash From Financing | -$431M | -$123.5M | -$387.5M | -$237.6M | -$104.4M | |
Beginning Cash (CF) | $1.3B | $385.1M | $176.9M | $833.8M | $129.1M | |
Foreign Exchange Rate Adjustment | $4M | $700K | $1.1M | $200K | -$700K | |
Additions / Reductions | -$517M | -$111.9M | $2.2B | $81.2M | -$5.7M | |
Ending Cash (CF) | $776M | $273.9M | $2.4B | $915.2M | $122.7M | |
Levered Free Cash Flow | $116M | $38.1M | $30.7M | $1M | -$17M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.